Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
USA v. Babich et al
Case Number:
1:16-cr-10343
Court:
Nature of Suit:
Judge:
Firms
- Brown Rudnick
- Clark Hill
- Donnelly Conroy
- Fick & Marx
- Fitch Law Partners
- Hogan Lovells
- King & Spalding
- Kobre & Kim
- Miner Siddall
- Mitchell Stein Carey
- Morgan Lewis
- Nixon Peabody
- Ropes & Gray
- Weil Gotshal
- White & Case
- Wilkinson Stekloff
Companies
Sectors & Industries:
-
January 16, 2019
Opioid User Testimony To Be Key Factor In Mass. Insys Trial
The day before hundreds of potential jurors descend on a Boston courtroom for a closely watched criminal case accusing former Insys Therapeutics Inc. executives of bribing doctors to prescribe opioids, attorneys sparred Wednesday over what patients who took the drug can say during the 14-week trial.
-
January 14, 2019
Exhibit List Ordered Trimmed After Insys Execs Blast Gov't
A group of former Insys Therapeutics Inc. executives charged with bribing doctors to prescribe the company's opioid spray lit into government lawyers Monday after prosecutors allegedly missed multiple disclosure deadlines, and a Massachusetts federal judge gave the government until midnight to trim its witness and exhibit list.
-
January 10, 2019
Ex-Insys Sales Rep Loses Bid To Split From Upcoming Trial
A former sales manager for Insys Therapeutics Inc. will have to stand trial at the end of the month with a quartet of company executives charged with bribing doctors to prescribe the company's fentanyl spray after a Massachusetts federal judge denied her motion for a separate trial Thursday.
-
January 09, 2019
Ex-Insys CEO Pleads Guilty, May Testify In Bribery Trial
In an eleventh-hour move, former Insys Therapeutics Inc. CEO Michael Babich admitted to taking part in a scheme to bribe doctors into prescribing the company's pricey fentanyl spray in Massachusetts federal court Wednesday and will cooperate as the criminal trial of his former co-workers kicks off later this month.
-
January 09, 2019
Insys Founder Need Not Comply With Subpoena, Judge Rules
Insys Therapeutics founder John Kapoor does not need to turn over his personal notes and other documents the government sought ahead of a trial for executives allegedly involved in an opioid kickback scheme, a federal judge in Boston ruled Tuesday, saying prosecutors failed to prove the records belonged to Insys and not to Kapoor himself.
-
January 02, 2019
Former Insys CEO Will Plead Guilty In Opioid Kickback Case
The former chief executive of Insys Therapeutics has agreed to plead guilty to conspiracy and mail fraud for his role in a scheme to bribe doctors to prescribe the company's fentanyl-based painkillers, prosecutors said in a court filing.
-
January 01, 2019
White Collar Cases To Watch In 2019
The coming year's white collar docket is an active one, with several large health care fraud cases set to go to trial and post-trial litigation that could shape the law in insider trading and other financial crimes and affect how companies cooperate in criminal probes.
-
December 18, 2018
Both Sides In Insys Case Violated Media Rules, Judge Says
A Boston federal judge issued a stern warning to lawyers on both sides of the Insys Therapeutics opioid kickback case on Monday, saying the U.S. Attorney's Office for Massachusetts and a defense attorney for Insys founder John Kapoor have each run afoul of court rules about talking to the media.
-
December 14, 2018
Feds Fight To Keep Insys Grand Jury Instructions Secret
Massachusetts federal prosecutors on Thursday fought a bid by Insys Therapeutics Inc. executives embroiled in an alleged conspiracy to bribe doctors into prescribing fentanyl-based drugs to disclose grand jury instructions, arguing the government did not wrongly explain the conspiracy charges.
-
December 06, 2018
Gov't Presses Judge To Force Insys Founder To Produce Docs
Prosecutors tried to persuade a Massachusetts federal judge to force the billionaire founder of Insys Therapeutics Inc. to hand over documents they say relate to their attempts to prove a conspiracy to bribe doctors, warning that failure to do so would back defendants' efforts to shield discovery during a hearing Thursday afternoon.